Asthma affects three million people in Canada, which is why treatments receive a lot of focus from professionals with a clinical research diploma. Learn more.
The complexities of the brain are staggering, so grads of clinical research courses are excited about a new link between magnets and memory recovery.
As many as 5.6 million prescriptions for sleeping pills are filled each year in Canada. Here’s a closer look at the fascinating history behind this medication.
Could the flu virus turn from foe to friend? Here’s what students with clinical research training need to know about its possible utility for fighting cancer.
Developing trials for orphan drugs after clinical research training can be a bit challenging. Find out why addressing the rarest of diseases may get tricky.
Height, weight, and gender are some of the standard factors looked at when determining the appropriateness or dosage of a medication, but even accounting for several of these may not result in a perfect solution. Accounting for the very genetic code of the individual who is meant to receive a treatment, though, could be the key to providing the precise care that is best suited for each person. Pharmacogenomics is the study of how the genome affects an individual’s reaction to a drug that enters their system. In an age of heightened focus on genetic modification and engineering, it is.. READ MORE »
The development of a dependable influenza (flu) vaccine was a major breakthrough for public health. For centuries, societies had suffered from seasonal outbreaks of this debilitating infectious disease. Nowadays, the lethal effect of the flu has been tempered in part via vaccination programs, but the disease still poses an ongoing risk, especially to the young, old, and those with compromised immune systems. Here’s how the ongoing development and persistent research around the vaccine has turned it into one of our enduring public health achievements. It’s a wonderful look into the important role that clinical researchers have in keeping the public.. READ MORE »
New drugs are developed, tested, processed, marketed, and then eventually released to the public every year. During their rigorous testing process, side effects arise in clinical trial patients and are noted by doctors. It is common for drugs to enter the market with a list of side effects, some being beneficial, but most being negative. These negative side effects are known as adverse effects. After a drug has been released to the market, there are systems in place so that healthcare professionals can report any new issues or serious reactions to drug. These are known as adverse drug reactions (ADRs)… READ MORE »
Wrist-worn heart rate tracking devices from companies like Fitbit are big business, and not just with athletes. According to recent estimates, there are over 100 medical studies in the United States alone that involve Fitbit devices, with several more that use bands from competing companies. The intended benefit of using these devices in studies is that they should allow researchers to collect quantitative data about their patients’ health, negating the need to use unreliable self-reported information. Research from California State Polytechnic University, Pomona, though, suggests that Fitbit’s continuous heart rate tracking “do[es] not accurately measure a user’s heart rate,” which.. READ MORE »
Every year, new drugs are put on the market with the intention of providing relief for suffering patients. These drugs have gone through years of research, testing, trials, and applications in order to be approved. Therefore, patients have some assurance that the drugs on the market meet certain safety and quality standards. To make that assurance, the Food and Drug Administration (FDA), much like Health Canada, uses a five-step drug development process. If you’re interested in a clinical research career, it is important to know each step in the process, as there is frequent collaboration between both governing bodies. Read.. READ MORE »
